Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 7, 2011 - Issue
Submit an article Journal homepage
388
Views
7
CrossRef citations to date
0
Altmetric
Review

Comparative efficacy of escitalopram in the treatment of major depressive disorder

Mazen K AliDepartment of Psychiatry, University of British Columbia, and Mood Disorders Centre, University of British Columbia Hospital, Vancouver, Canada
&
Raymond W LamDepartment of Psychiatry, University of British Columbia, and Mood Disorders Centre, University of British Columbia Hospital, Vancouver, CanadaCorrespondence[email protected]
Pages 39-49 | Published online: 01 Feb 2011

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Daniel Souery, Raffaella Calati, Konstantinos Papageorgiou, Alzbeta Juven-Wetzler, Joël Gailledreau, David Modavi, Othman Sentissi, William Pitchot, George N. Papadimitriou, Dimitris Dikeos, Stuart Montgomery, Siegfried Kasper, Joseph Zohar, Alessandro Serretti & Julien Mendlewicz. (2015) What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram. The World Journal of Biological Psychiatry 16:7, pages 472-482.
Read now
Devin Pastoor & Joga Gobburu. (2014) Clinical pharmacology review of escitalopram for the treatment of depression. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 121-128.
Read now
Gaël Quesseveur, Hai T Nguyen, Alain M Gardier & Bruno P Guiard. (2012) 5-HT2 ligands in the treatment of anxiety and depression. Expert Opinion on Investigational Drugs 21:11, pages 1701-1725.
Read now

Articles from other publishers (4)

Cheolmin Shin, Sang Won Jeon, Seung-Hoon Lee, Chi-Un Pae, Narei Hong, Hyun Kook Lim, Ashwin A. Patkar, Prakash S. Masand, Hyonggin An & Changsu Han. (2023) Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial. Clinical Psychopharmacology and Neuroscience 21:1, pages 135-146.
Crossref
Manal E. Alkahtani, Alhassan H. Aodah, Omar A. Abu Asab, Abdul W. Basit, Mine Orlu & Essam A. Tawfik. (2021) Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder. Pharmaceutics 13:6, pages 891.
Crossref
Madhavi Kodali, Srikanth Lella, Sarath Bodepudi, Therissa Benerji & Krishna Mohan Parvathaneni. (2021) Effectiveness and side-effect profile of Vilazodone and Escitalopram in major Depressive Disorder – An observational study. IP Indian Journal of Neurosciences 7:1, pages 20-25.
Crossref
Bruno Campos, Claudia Rivetti, Timm Kress, Carlos Barata & Heinrich Dircksen. (2016) Depressing Antidepressant: Fluoxetine Affects Serotonin Neurons Causing Adverse Reproductive Responses in Daphnia magna . Environmental Science & Technology 50:11, pages 6000-6007.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.